copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Myc - Wikipedia The Myc family consists of three related human genes: c-myc (MYC), l-myc (MYCL), and n-myc (MYCN) c-myc (also sometimes referred to as MYC) was the first gene to be discovered in this family, due to homology with the viral gene v-myc
The MYC oncogene — the grand orchestrator of cancer growth and immune . . . MYC has two paralogues: MYCL and MYCN The initially held view was that MYC is ubiquitously involved in human cancers (both haematological and solid), whereas L-MYC is associated with small-cell lung cancer and N-MYC with neuroblastoma
MYC Gene - GeneCards | MYC Protein | MYC Antibody MYC (MYC Proto-Oncogene, BHLH Transcription Factor) is a Protein Coding gene Diseases associated with MYC include Burkitt Lymphomaand High-Grade B-Cell Lymphoma Double-Hit Triple-Hit
Myc - an overview | ScienceDirect Topics MYC is a proto-oncogene that encodes a powerful regulator of transcription and cellular programs essential for normal development, as well as the growth and survival of various types of cancer cells MYC rearrangement and amplification is a common cause of hematologic malignancies
MYC: there is more to it than cancer - PMC MYC is a pleiotropic transcription factor involved in multiple cellular processes While its mechanism of action and targets are not completely elucidated, it has a fundamental role in cellular proliferation, differentiation, metabolism, ribogenesis, and bone and vascular development
MYC on the Path to Cancer: Cell MYC produces the transcription factor Myc, which dimerizes with Max and binds target DNA sequences or E boxes (with the sequence 5′-CANNTG-3′) to regulate transcription of genes involved in cell growth and proliferation
The effects of MYC on tumor immunity and immunotherapy The abnormal expression of MYC is one of the most common carcinogenic events in human cancer MYC modulates immune effector cells and immune regulatory factors in the tumor immune